News
Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $16.50 Price Valuation
26 Aug 24
News, Analyst Ratings, Trading Ideas
MIRA Pharmaceuticals' Oral Ketamine Analog Achieves Complete Normalization Of Neuropathic Pain In Animal Studies
26 Aug 24
Biotech, Equities, News, Health Care, Movers, Trading Ideas, General
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
26 Aug 24
News, Pre-Market Outlook, Markets, Movers, Trading Ideas
Heico, PDD Holdings And 3 Stocks To Watch Heading Into Monday
26 Aug 24
Earnings, News, Pre-Market Outlook, Markets, Trading Ideas
MIRA Pharmaceuticals Nears IND Submission, Strengthens Leadership and Drug Development Progress
19 Aug 24
Government, News, Regulations
Watching MIRA Pharmaceuticals; Shares See Volume After Zacks Small-Cap Research Gives Stock $16.50 Price Valuation
14 Aug 24
News, Analyst Ratings, Trading Ideas
Telomir Pharmaceuticals Mourns The Passing Of Chairman And CEO Christopher Chapman, Has Named Erez Aminov As A Director, Chairman Of The Board And CEO
12 Aug 24
News, Management
Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
5 Aug 24
News, Markets, Movers, Trading Ideas
Ascendiant Capital Initiates Coverage On Mira Pharmaceuticals with Buy Rating, Announces Price Target of $11
5 Aug 24
News, Price Target, Initiation, Analyst Ratings
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?
1 Aug 24
Top Stories, Exclusives, Tech, Trading Ideas, ETFs
(MIRA) - Analyzing Mira Pharmaceuticals's Short Interest
26 Jul 24
Short Sellers, Short Ideas, Trading Ideas
Mental Health Disorders-Focused MIRA Pharmaceuticals Unveils Additional Preclinical Data
25 Jul 24
Biotech, News, Health Care, Top Stories, Movers
MIRA Pharmaceuticals Announced New Insights Garnered From Additional, Recently Received Preclinical Study Data Regarding The Mechanism Of Action And Toxicology Data For Its Oral Ketamine Analog, Ketamir-2
25 Jul 24
Biotech, News, Health Care, General
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
23 Jul 24
Intraday Update
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
23 Jul 24
News, Pre-Market Outlook, Markets, Movers, Trading Ideas
S&P 500 Gains 1%; MIRA Pharmaceuticals Shares Spike Higher
22 Jul 24
News, Eurozone, Commodities, Intraday Update, Markets, Trading Ideas
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
22 Jul 24
News, Intraday Update, Markets, Movers, Trading Ideas
Dow Edges Lower; Verizon Shares Fall After Q2 Results
22 Jul 24
Earnings, News, Eurozone, Commodities, Intraday Update, Markets, Trading Ideas
Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Report Being Circulated, Gives Co $16.50 Price Valuation
22 Jul 24
News, Analyst Ratings, Trading Ideas
Nano-Cap MIRA Pharmaceuticals' Oral Ketamine Analog Shows Potential In Neuropsychiatric Disorders
22 Jul 24
News, Top Stories, Movers
Press releases
MIRA Pharmaceuticals Achieves 100% Reversal of Neuropathic Pain With Oral Ketamir-2 in Breakthrough Study
26 Aug 24
News, Press Releases
MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End
19 Aug 24
News, Press Releases
Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman
12 Aug 24
News, Management, Press Releases
MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor
12 Aug 24
News, Press Releases
MIRA Pharmaceuticals (NASDAQ: MIRA) Reports Promising Pre-Clinical Trial Results For Mental Health Treatment, To Submit Investigational New Drug Application By End Of Year
29 Jul 24
MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2's Selective NMDA Binding Mechanism of Action
25 Jul 24
News, Press Releases
MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy
23 Jul 24
News, Press Releases
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
22 Jul 24
News, Press Releases
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
15 Jul 24
News, Press Releases
Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year
10 Jun 24
Press Releases
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
29 May 24
Press Releases